We read with interest the publications in the JEADV which reported dermatological manifestations associated with COVID‐19, such as pityriasis rosea, urticaria, rash, vascular signs, or chilblain‐like lesions. Herein, we report two life‐threatening cases of children presenting with fever and eruptions with mucous membrane involvement – erythema multiforme and Kawasaki disease – associated with COVID‐19.